
Founder Lobular Breast Cancer Alliance. Writer. Former political hack. Living w/ #lobular #breastcancer & #ovariancancer. Cancer Research Advocate. Tweets mine
Seattle, WA USA
Joined December 2009
- Tweets2.4K
- Following525
- Followers735
- Likes3.6K
Good things happen when research evals #lobular #breastcancer separately from #IDC. Meaningful for #metastatic #ILC patients #bcsm 👇
news-medical.net/news/202206…
Leigh Pate retweeted
Dear #cancer researchers ... How are you engaging w/ patients & patient advocates at your institutions? Are they a last minute box to be checked on your grant proposals? Or are they partners in your research? #PatientEngagement #PatientAdvocacyMovesScience 👇👇👇
Everyone who knows even a little #regulatory history knows that patient #advocacy moves science forward. I have endless admiration for @bsw5020 & @sabrevaya.
Leigh Pate retweeted
Great video @LobularBCA. I have seen #lobular cancers missed on screening mammography be detected on MRI, CEM, MBI and US. Although access may be limited, supplemental screening for #ILC may be key, especially for those with #densebreast tissue.
youtu.be/xNoXveXGC2g
Leigh Pate retweeted
🟡#breastcancer and the #PTEN hamartoma tumor syndrome (PHTS, previously #Cowden): screening with MRI led to the detection of cancer in 7 women/39 enrolled. All early-stage, all ductal (no #lobular). Median FU: 4 years. No benefit of adding mammography. acsjournals.onlinelibrary.wi…
Nice write-up and #breastcancer #advocate Lori Petitti @hiplinemedia
@jackel626 @maggiemoo09 @double_whammied @oesterreichs @mjsikora
This Post is from an account that no longer exists. Learn more
Sounds like #ILCSymposium 2022 was a hit on all accounts! Thanks to all who worked so hard. Onward! 👇
@ChristineDesme2 @PWBDerksen @Otto_DFCI @oesterreichs @BCRFcure @AVincentSalomon @LobularBCUK @LobularIreland @elbcc @LobularBCA #bcsm
Replying to @oesterreichs
Fantastic presentations and great posters by trainees - everyone put great effort into it. 🙏. Collectively more evidence for #lobular being a distinct breast cancer that deserves more studies. And need to move findings into clinical trials! @neil_carleton_ @Adrianvlee
Leigh Pate retweeted
👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
10yrs cancer free today incredibly grateful!Proud what our foundation has done funding#lobular #ILC #unmetneed collab is key @hoosierdfh @mjsikora @Adrianvlee @oesterreichs @UMRogelCancer @sofiamerajver @paigelmyers @UPMCHillmanCC
Leigh Pate retweeted
Respect 🙌 and Gratitude 🙏
To #Lobmob Leader @LPseattle from the entire attendance at The International Lobular Breast Cancer Symposium #ILCSymposium
Leigh Pate retweeted
Since we missed @LPseattle from the #ILCSymposium @oesterreichs read her message and she received a huge huge applause @LobularBCA
Steffi Oestenreich reading a very touching speach by patient advocate Leigh Pate. It would have been great to meet you here at #ILCSymposium. @oesterreichs @LPseattle
LOVE IT! International #Lobular #breastcanceer Advocacy has launched and is flying! Onward!
We wrap up the Patient Advocate Session with, appropriately, a photo of the patient advocates attending #ILCSymposium. @elbcc @LobularBCUK @LobularIreland
Leigh Pate retweeted
Val Brunton from @EdinCRC , one of our Scientific Advisor’s talking about the #lobular tumour microenvironment. #ILCSymposium
Leigh Pate retweeted
Impressive talk about ##ILC immune features, #Ecadherin #Pcadherin switching and #metastatic ILC #heterogeneity #clonal evolution @NatrajanLabICR
The afternoon session continues at #ILCSymposium with Rachel Natrajan speaking on the heterogeneity of E-cadherin and the immune microenvironment in #lobular #breastcancer. @elbcc @LobularIreland @LobularBCUK
Leigh Pate retweeted
Following quite a spectacular Patient Advocate led Session this morning we have an even more Spectacular Key Note Speaker #DAY2 Sabine Linn is now speaking
'Toward Precision Medicine for ILC'
#ILCSymposium #Utrecht
Such a great resource for patients with #lobular #breastcancer in 🔟 languages 🎉. Download and share 👇
Honored to talk about the leaflet of @elbcc we created for and with the patients diagnosed with lobular breast cancer this morning at the #ILCSymposium. elbcc.org/Leaflet #Koorman @BreastDense @LobularBCUK @LobularIreland @ClaireTTweets @tonelien #rianterveer #gabrielebeck
Important poster presentation from @LobularBCUK at #ILCSymposium exploring Delphi study results on improving care for patients with #lobular #breastcancer 👇👇👇👇 turns out lobular patients NEED tailored care and follow up #bcsm
Fabulous first day at the #ILCSymposium. A lot of new research, shared ideas & finally met our partner scientists, clinicians & patient advocates. We got to share our first poster collaboration with @dmuleicester. #lobular #BreastCancer @LWalters2021 @DrHCoulthard @QuinceyKerry
Leigh Pate retweeted
New research out on early-stage #lobular #breastcancer. Older women (70+) may not need to have sentinel node biopsy.
Thanks @oesterreichs @Adrianvlee et al for making sure #lobularBC is always included in research! #lobmob @LPseattle @LobularBCA
This Post is from an account that no longer exists. Learn more
Post-mortem tissue study promising to help understand #metastatic #lobular #breastcancer #bcsm @VanBaelenKaren
Our last speaker for the day at the #ILCSymposium is @VanBaelenKaren speaking on enhancing research on metastatic #lobular #breastcancer through a postmortem tissue donation study. @elbcc @LobularBCUK @LobularIreland
Leigh Pate retweeted
Closing out today at the #ILCSymposium is LBCA Scientific Advisor Dr. Rachel Jankowitz moderating a session with our three funded #lobular #breastcancer researchers! @elbcc @LobularIreland @LobularBCUK
International #lobular #breastcancer advocates meeting, greeting and getting to know each other at #ILCSymposium Utrecht! @LobularBCUK @LobularIreland @LobularBCA @elbcc
Working Lunch #ILC Breast Cancer Patients and Advocates from Europe US UK share experiences around Dx / Treatment. We're looking forward to further developing a European Advocate presence, influencing #Lobular BC Tx / Screening protocols in EU
#ILCSymposium



























